Navigation Links
Ingenuity Systems and Covance Collaborate to Support Next-Generation Sequencing Research
Date:2/23/2011

REDWOOD CITY, Calif., Feb. 23, 2011 /PRNewswire/ -- Ingenuity® Systems, a leading provider of information and analytics solutions for life science researchers, today announced a research collaboration with Covance Genomics Laboratory (www.covance.com/cgl) for next-generation sequencing (NGS) data analysis. Covance Genomics Laboratory, a leading provider of genomics solutions for the drug discovery and development industry, and Ingenuity will work together to develop new and novel approaches, using Ingenuity's IPA® software, to obtain more actionable insights from NGS data and to answer research questions in a relevant biological context.

This collaboration brings together leaders in genomics data production and analysis to develop new methodologies that integrate high-quality NGS data with industry-leading knowledge generation and management tools.  By working together to generate the next generation of biological interpretation tools, Covance Genomics Laboratory will have the unique ability to help its pharmaceutical clients maximize the value of their investment in NGS technologies.  IPA relieves the NGS data analysis bottleneck by providing the biological context necessary to move past the long noisy lists of genes, isoforms, and variants, helping to uncover those that are most critical to biology.  This enables researchers to quickly get to the intended high-value results of biomarker identification, target ID and validation, understanding drug mechanism of action, and safety assessment.

"We're delighted that Covance has selected IPA for its NGS workflows," said Doug Bassett, Ph.D., CSO and CTO, Ingenuity Systems. "We've been involved in several NGS collaborations recently, and our partnership with Covance, a leading drug development services company, represents another powerful validation of IPA's value in the NGS space. It is exciting to see IPA being used to accelerate and inform so much groundbreaking research."

Having run more than 450,000 samples to date, Covance Genomics Laboratory provides end-to-end services for genomics-based development research and has demonstrated particular expertise in NGS.  "The complexity of next-generation sequencing data can be a challenge to translational science and medicine," stated Tom Turi, Vice President, Science & Technology, Covance Discovery & Translational Services. "We're confident the combination of our best-in-class genomics data and the high-quality biological content and context provided by IPA will result in the delivery of more rapid, accurate, and thorough research services for our customers."  

About Ingenuity® Systems

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. For more information visit: www.ingenuity.com


'/>"/>
SOURCE Ingenuity Systems
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity
2. Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
3. Ingenuitys Technology Powers BD Cell Pathways Tool on New BD Biosciences Website
4. Ingenuity Systems Announces New Distributor for Greece, Turkey and the Balkans
5. Ingenuity Systems Announces Toxicogenomics Best Practices White Paper
6. Ingenuity Systems and Sage Bionetworks Collaborate to Enable Predictive Disease Network Research
7. Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research
8. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
9. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
10. Avantis Medical Systems, Inc. Announces Key Leadership Appointments
11. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
(Date:6/22/2016)... Research and Markets has announced the addition of the "Biomarkers: ... The global biomarkers market has grown ... market is expected to grow at a five-year compound annual growth ... billion in 2015 to $96.6 billion in 2020. ... 2020) are discussed. As well, new products approved in 2013 and ...
Breaking Biology Technology:
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):